Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
POLR3-related disorder revealed by movement disorders.
Tailland M, Gonzalez V, Prin P, Carra-Dallière C, Ayrignac X, Labauge P. Tailland M, et al. Among authors: prin p. Rev Neurol (Paris). 2021 Mar;177(3):328-330. doi: 10.1016/j.neurol.2020.06.013. Epub 2020 Sep 28. Rev Neurol (Paris). 2021. PMID: 33004219 No abstract available.
A regional strategy to decrease the time to thrombectomy in patients with low probability of treatment by thrombolysis.
Ter Schiphorst A, Duflos C, Mourand I, Gaillard N, Dargazanli C, Corti L, Prin P, Lippi A, Ayrignac X, Charif M, Wacongne A, Bouly S, Lalu T, Sablot D, Blanchet-Fourcade G, Landragin N, Jacob F, Sayad C, Derraz I, Cagnazzo F, Lefevre PH, Gascou G, Beaufils O, Costalat V, Arquizan C. Ter Schiphorst A, et al. Among authors: prin p. Rev Neurol (Paris). 2022 Jun;178(6):558-568. doi: 10.1016/j.neurol.2021.11.001. Epub 2021 Dec 10. Rev Neurol (Paris). 2022. PMID: 34903351
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size.
Costalat V, Jovin TG, Albucher JF, Cognard C, Henon H, Nouri N, Gory B, Richard S, Marnat G, Sibon I, Di Maria F, Annan M, Boulouis G, Cardona P, Obadia M, Piotin M, Bourcier R, Guillon B, Godard S, Pasco-Papon A, Eker OF, Cho TH, Turc G, Naggara O, Velasco S, Lamy M, Clarençon F, Alamowitch S, Renu A, Suissa L, Brunel H, Gentric JC, Timsit S, Lamy C, Chivot C, Macian-Montoro F, Mounayer C, Ozkul-Wermester O, Papagiannaki C, Wolff V, Pop R, Ferrier A, Chabert E, Ricolfi F, Béjot Y, Lopez-Cancio E, Vega P, Spelle L, Denier C, Millán M, Arenillas JF, Mazighi M, Houdart E, Del Mar Freijo M, Duhamel A, Sanossian N, Liebeskind DS, Labreuche J, Lapergue B, Arquizan C; LASTE Trial Investigators. Costalat V, et al. N Engl J Med. 2024 May 9;390(18):1677-1689. doi: 10.1056/NEJMoa2314063. N Engl J Med. 2024. PMID: 38718358 Clinical Trial.
Reversible giant arachnoid granulations.
Taieb G, Dargazanli C, Prin P, Charif M, Ducros A. Taieb G, et al. Among authors: prin p. Neurology. 2018 Dec 11;91(24):1107-1108. doi: 10.1212/WNL.0000000000006656. Neurology. 2018. PMID: 30530555 No abstract available.
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity.
Ayrignac X, Le Bars E, Duflos C, Hirtz C, Maleska Maceski A, Carra-Dallière C, Charif M, Pinna F, Prin P, Menjot de Champfleur N, Deverdun J, Kober T, Marechal B, Fartaria MJ, Corredor Jerez R, Labauge P, Lehmann S. Ayrignac X, et al. Among authors: prin p. Sci Rep. 2020 Jul 2;10(1):10923. doi: 10.1038/s41598-020-67934-2. Sci Rep. 2020. PMID: 32616916 Free PMC article.
CSF β-amyloid is not a prognostic marker in multiple sclerosis patients.
Petitfour J, Ayrignac X, Ginestet N, Prin P, Carra-Dallière C, Hirtz C, Charif M, Lehmann S, Labauge P. Petitfour J, et al. Among authors: prin p. Mult Scler Relat Disord. 2022 Dec;68:104096. doi: 10.1016/j.msard.2022.104096. Epub 2022 Aug 8. Mult Scler Relat Disord. 2022. PMID: 36037751
20 results